NPY methylated ctDNA is a promising biomarker for treatment response monitoring in metastatic colorectal cancer

Katleen Janssens
katleen.janssens@uantwerpen.be

Request Access

Dataset ID	Description	Technology	Samples
EGAD00001009796	12.5 ng of cfDNA was used as input for shallow whole-genome sequencing (sWGS), aiming for a coverage of x0.2-0.4-fold. Library preparation was performed using the TruSeq Nano DNA High Throughput Library Prep Kit (Illumina, San Diego, CA, USA) on an automated Hamilton STAR liquid handling system (Hamilton, Germany GmbH, Robotics, Gräfeling, Germany) with dual indexing, and sequencing was performed on the NextSeq500/550 platform (Illumina). The fraction of tumor-derived DNA in cell-free DNA was estimated using the R package ichorCNA.	NextSeq 500	1